LUTONIX
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. Paclitaxel is an anti-proliferative drug commonly used to prevent arterial restenosis. Lutonix DCB is very similar to a standard angioplasty balloon, but contains a special coating consisting of paclitaxel and a proprietary carrier that facilitates the drug’s transfer to the arterial wall upon inflation. This highly efficient formulation allows Lutonix DCB to deliver a therapeutic dose to the artery wall, while keeping the dose of paclitaxel on the balloon as low as possible. A lower balloon drug load minimizes systemic drug exposure and is designed to maximize safety.
LUTONIX
Industry:
Biotechnology Health Care Medical Device
Founded:
2007-01-01
Address:
Maple Grove, Minnesota, United States
Country:
United States
Website Url:
http://www.lutonix.com
Total Employee:
11+
Status:
Active
Contact:
763-445-2352
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
Microsoft Azure DNS Liquid Web MarkMonitor DNS
Similar Organizations
Kintai Therapeutics
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Current Employees Featured
Founder
Investors List
Delphi Ventures
Delphi Ventures investment in Series B - Lutonix
U.S. Venture Partners
U.S. Venture Partners investment in Series B - Lutonix
RiverVest
RiverVest investment in Series B - Lutonix
Versant Ventures
Versant Ventures investment in Series B - Lutonix
Official Site Inspections
http://www.lutonix.com
- Host name: aeedc42b70c898c66.awsglobalaccelerator.com
- IP address: 3.33.139.32
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
